These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 29416785)

  • 1. Predictors of lymphovascular invasion identified from pathological factors in Chinese patients with breast cancer.
    Shen S; Xiao G; Du R; Hu N; Xia X; Zhou H
    Oncotarget; 2018 Jan; 9(2):2468-2474. PubMed ID: 29416785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction model of lymphovascular invasion based on clinicopathological factors in Chinese patients with invasive breast cancer.
    Shen S; Wu G; Xiao G; Du R; Hu N; Xia X; Zhou H
    Medicine (Baltimore); 2018 Oct; 97(43):e12973. PubMed ID: 30412123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
    Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
    Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The levels of Ki-67 positive are positively associated with lymph node metastasis in invasive ductal breast cancer.
    Yin Y; Zeng K; Wu M; Ding Y; Zhao M; Chen Q
    Cell Biochem Biophys; 2014 Nov; 70(2):1145-51. PubMed ID: 24879617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma.
    Lin CS; Chang SC; Ou LH; Chen CM; Hsieh SS; Chung YP; King KL; Lin SL; Wei YH
    Oncol Rep; 2015 Jun; 33(6):2924-34. PubMed ID: 25845386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.
    Kurebayashi J; Kanomata N; Shimo T; Yamashita T; Aogi K; Nishimura R; Shimizu C; Tsuda H; Moriya T; Sonoo H
    Breast Cancer; 2014 Mar; 21(2):214-22. PubMed ID: 22689016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2-40, Podoplanin, and CD31 as a Prognostic Predictor in Invasive Ductal Carcinomas of the Breast.
    Lee JA; Bae JW; Woo SU; Kim H; Kim CH
    J Breast Cancer; 2011 Jun; 14(2):104-11. PubMed ID: 21847404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients.
    Alco G; Bozdogan A; Selamoglu D; Pilanci KN; Tuzlali S; Ordu C; Igdem S; Okkan S; Dincer M; Demir G; Ozmen V
    Oncol Lett; 2015 Mar; 9(3):1046-1054. PubMed ID: 25663855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is lymphovascular invasion degree one of the important factors to predict neoadjuvant chemotherapy efficacy in breast cancer?
    Uematsu T; Kasami M; Watanabe J; Takahashi K; Yamasaki S; Tanaka K; Tadokoro Y; Ogiya A
    Breast Cancer; 2011 Oct; 18(4):309-13. PubMed ID: 20574730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
    Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
    Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between lymphovascular invasion and molecular subtypes in invasive breast cancer.
    Morkavuk ŞB; Güner M; Çulcu S; Eroğlu A; Bayar S; Ünal AE
    Int J Clin Pract; 2021 Apr; 75(4):e13897. PubMed ID: 33280209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF), and e-cadherin in a high-risk breast-cancer population.
    Howard EM; Lau SK; Lyles RH; Birdsong GG; Tadros TS; Umbreit JN; Kochhar R
    Int J Clin Oncol; 2004 Jun; 9(3):154-60. PubMed ID: 15221598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.
    Yoshimura T; Nagahara M; Kuo C; Turner RR; Soon-Shiong P; Hoon DS
    Epigenetics; 2011 Aug; 6(8):1001-11. PubMed ID: 21725199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy.
    Liu YL; Saraf A; Lee SM; Zhong X; Hibshoosh H; Kalinsky K; Connolly EP
    Breast Cancer Res Treat; 2016 Jun; 157(3):555-64. PubMed ID: 27225388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
    BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presenting features of breast cancer differ by molecular subtype.
    Wiechmann L; Sampson M; Stempel M; Jacks LM; Patil SM; King T; Morrow M
    Ann Surg Oncol; 2009 Oct; 16(10):2705-10. PubMed ID: 19593632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice.
    Yoshihara E; Smeets A; Laenen A; Reynders A; Soens J; Van Ongeval C; Moerman P; Paridaens R; Wildiers H; Neven P; Christiaens MR
    Breast; 2013 Jun; 22(3):357-61. PubMed ID: 23022046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer.
    Pathmanathan N; Balleine RL; Jayasinghe UW; Bilinski KL; Provan PJ; Byth K; Bilous AM; Salisbury EL; Boyages J
    J Clin Pathol; 2014 Mar; 67(3):222-8. PubMed ID: 24403187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.